ThomasHBurwinkelMD
Obstetrics & Gynecology • Kettering, OHReproductive Endocrinology & Infertility
Institute for Reproductive Health
Dr. Burwinkel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3533 Southern Blvd
Ste 4100
Kettering, OH 45429Phone+1 937-395-8444Fax+1 937-395-8455
Summary
- Dr. Thomas Burwinkel is an obstetrician/gynecologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including Miami Valley Hospital and Christ Hospital. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 31 years. He specializes in reproductive endocrinology & infertility and is experienced in reproductive and sexual endocrinology and reproductive genetics.
Education & Training
TriHealth (Bethesda Hospital)Residency, Obstetrics and Gynecology, 1986 - 1990
University of Cincinnati College of MedicineClass of 1986
Certifications & Licensure
KY State Medical License 1987 - 2025
OH State Medical License 1987 - 2025
TN State Medical License 1990 - 1992- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 2 citationsPlatelet activating factor treatment of spermatozoa enhances rabbit oocyte fertilization following subzonal sperm insertionBrijinder S. Minhas, Hak Nam Kim, Y.P. Zhu, Barry A. Ripps, Thomas H. Burwinkel
Journal of Assisted Reproduction and Genetics. 1994-07-01 - 1 citationsEmbryo survival after pronuclear microinjection and trophectoderm biopsy.Thomas H. Burwinkel, Hak-Nam Kim, John E. Buster, Brijinder S. Minhas, Sandra Ann Carson
American Journal of Obstetrics and Gynecology. 1994-04-01 - 13 citationsBasal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)-intrauterine insemination (IUI) therapy.Thomas H. Burwinkel, John E. Buster, Janet L. Scoggan, Sandra A. Carson
Journal of Assisted Reproduction and Genetics. 1994-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
